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Importance of this Research
We chose to research the eﬀectiveness of spacer devices because we
recognized major issues that are surrounding the standard-prescribed
metered-dose inhalers. Throughout our research, we discovered that metered-dose
inhalers do not always eﬀectively deliver medication to a patient's lungs due to the
increased need for hand-breath coordination and a higher risk of developing oral
thrush. We wanted to learn more about the beneﬁts of using a spacer device to
include mechanics behind the delivery of medication, how cost eﬀective it is to
patients and facilities, its eﬀects of hospital admission and readmission rates, and
patients overall device preference.

Inhalation Medication Administration Methods
●
●
●
●
●

Metered dose inhalers (MDI)
Breath actuated aerosol inhalers
Dry powder inhalers
Nebulizers
Spacer devices
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How does the spacer device
help deliver medication?
●

●

●

After a patient presses down on the
inhaler, they usually have to time it just
right in order for the medication to
eﬀectively reach their lungs.
A spacer holds the “puﬀ” of medication
in the device so that there is more time
for it to be inhaled slowly and more
completely.
This enables the medication to be
inhaled directly into the lungs.
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Beneﬁts of Using a Spacer Device
●
●
●

●
●
●
●

Provides asthma patients with a simpler
concept to learn and understand
Reduces the need for coordination between
pressing the inhaler and breathing in
Devices contains a whistle that indicates to
patients if they inhaled too quickly for
medication to properly administer
Allows for a greater concentration of
medication to be absorbed into the lungs
Reduces the risk for oral thrush
Reduces unwanted swallowing of drug and
gastrointestinal absorption
Saves more medication
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Cost Effectiveness of Spacers
●

●

For Patients:
○ A study in Nova Scotia concluded that
patients save around $24 when they use
an MDI with spacer device compared to a
nebulizer machine.
■ Over 800 patients who went to the
pediatric emergency department
were used in this study.
In the hospital setting:
○ Spacers were found to oﬀer a more cost
eﬀective option for asthma patients in the
hospital when compared to a nebulizer
machine.
■ The AAP study concluded an
average savings of $154.95 per
patient.

●

Overall:
○ By decreasing the costs in hospitals,
health care systems and families also
experience an overall cut in their
treatment costs as well.

Figure 1: Dewar AL, Stewart A, Cogswell JJ, Connett GJ. A randomised controlled trial to
assess the relative benefits of large volume spacers and nebulisers to treat
acute asthma in hospital. Arch Dis Child. 1999;80(5):421–423.
doi:10.1136/adc.80.5.421
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Use of Spacer Devices on Hospital Admission Rates
The study in Nova Scotia also concluded those who chose to use a MDI with a spacer
as treatment versus those who use nebulizers saw a decrease in the need for
hospitalization by 4.4% as well as a reduction in the average inpatient stay by 25 hours.
Another study done that was randomized at a children’s emergency department looked
into children ages 1-4 taken to the hospital.
● The study concluded that children using a nebulizer saw an admission rate of 60%
and an admission rate of 33% for those who were using MDIs with spacers.
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Use of Spacer Devices on Hospital Readmission Rates
When comparing hospitalizations among patients who use MDIs with spacers and
those who use nebulizers, it was found that those who use MDIs with spacers
experience less readmission rates to hospitals.
● A study completed over a 12 month period at Southampton University Hospital
and Poole District General Hospital on children over the age of 3 found patients
who used the spacer had a readmission rate of 13.8% when the nebulizer group
had a readmission rate of 27.2%.
○

In the study, there was no signiﬁcant diﬀerence found in clinical characteristics and severity of the
attack among the groups when admitted the ﬁrst time.
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Parent and Child Preference
A study completed over a 3 month period at the Sydney Children’s Hospital
emergency department was done to ﬁnd parent and child satisfaction with diﬀerent
asthma treatment options.
● 158 parents were surveyed and 84% reported they found a spacer easy to use and
that they intended to use it at home.
○

●

Of the parents who previously had nebulizers for their children, 84% said they would be switching
to spacers
■ Majority also reported that their children tolerated this treatment better than a nebulizer

30 children were between the ages of 8-14 and 82% of them reported the spacer
being easier or quicker to use compared to other
treatment options.
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Adult Preference
A study was done over 2.5 years in a large urban
emergency department to research adult satisfaction
with treatment when using MDIs with spacers versus
nebulizer treatments.
● Patients in the group treated with MDIs with
spacers experienced a great improvement in their
peak-ﬂow when compared to the other treatment
group.
● These patients also rated high satisfaction due to
experiencing a shorter time in the hospital when
using a spacer device with a MDI.
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Conclusion
Overall, MDIs with spacers have been found to be favored among all ages of
patients. The addition of a spacer has been found to be more cost eﬀective for hospitals
and patients when compared to other forms of medication delivery. Also, spacers have
been linked to lower hospital admissions as well as lower hospital readmissions when
compared to other treatment options.
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